CGAS and breast cancer: Upon deletion of cGAS using CRISPR-Cas9 or upon chemical inhibition of cGAS, several human and mouse breast cancer cell lines (BT594, 4T1) showed higher rates of apoptosis upon chromosomal mis-segregation.